Smith & Nephew, an English medical device player, is up 7% over the last year. Above: Smith & Nephew’s REGENETEN bioinductive implant. (Courtesy Smith & Nephew)After enduring a prolonged stretch of underperformance, medical device stocks are beginning to show early signs of stabilization as investors rotate back toward defensive growth areas of the healthcare sector.
Medical Device Stocks Are Ready to Bounce. Two Names to Buy Now.
Glaukos, a medical technology company focusing on eye disorders, has achieved gains of 20% year to date and 48% over the last year.
55 words~1 min read
